SCHEMBL8774866

SCHEMBL8774866

COc1ccc(F)c(-c2nc(O)cc(O)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.51
NPC1 O15118 5/20 0.50
GRK6 P43250 1/20 0.43
RAB9A P51151 3/20 0.42
CYP19A1 P11511 1/20 0.41
PDE2A O00408 2/20 0.40
PDE10A Q9Y233 2/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
KDM1A O60341 1/20 0.40
PDE6D O43924 1/20 0.40
PDE6A P16499 1/20 0.40
PDE6G P18545 1/20 0.40
PDE4A P27815 1/20 0.40
PDE6B P35913 1/20 0.40
PDE6C P51160 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE3B Q13370 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8774775 0.77 IDH2 (0.44) IDH2NPC1GRK6RAB9AHSD17B1
SCHEMBL8344303 0.75 HTR2B (0.42) NPC1RAB9ACYP19A1PDE4DMEN1
SCHEMBL16424643 0.75 RECQL (0.37) IDH2NPC1RAB9APDE2APDE10A
SCHEMBL2118153 0.73 ESR2 (0.52) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL16318931 0.71 NPC1 (0.45) NPC1RAB9ACYP19A1MEN1KMT2A
SCHEMBL8774927 0.71 ALDH1A1 (0.44) IDH2NPC1GRK6RAB9AMEN1
SCHEMBL1711956 0.71 CTSA (0.50) GRK6MAPTALDH1A1SMN1; SMN2
SCHEMBL13030444 0.71 NPC1 (0.77) NPC1RAB9APDE4APDE4DMEN1
SCHEMBL10645528 0.70 ADORA3 (0.52) NPC1RAB9ACYP19A1USP2ALOX15
SCHEMBL1620598 0.70 NPC1 (0.53) NPC1RAB9ACYP19A1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688654-A GAMMA-AMINOBUTYRIC ACID NEUROGEN CORPORATION (US) 1997-11-18 US disclosed
EP-0639275-B1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORP (US) 1997-09-17 EP disclosed
US-5597920-A Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes NEUROGEN CORPORATION (US) 1997-01-28 US disclosed
EP-0639275-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES. NEUROGEN CORP (US) 1995-02-22 EP disclosed
WO-1993022681-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORPORATION (US) 1993-11-11 WO disclosed